Search results for "intrexon"

Why Intrexon Corporation Stock Got Crushed Today - Madison.com

Posted By BioSocrates on synthetic biology

http://news.google.com - WeeklyHubWhy Intrexon Corporation Stock Got Crushed TodayMadison.comShares of the synthetic-biology company Intrexon Corporation (NYSE: XON) lost over a quarter of their value today -- down 25.63% -- on nearly nine times the average daily volume. The culprit? An extremely disappointing third-quarter earnings release ...Intrexon Corporation (XON) Moves Lower on Volume Spike for November 10Equities.comMoody Stock Sees Increased Volatility Levels in Session: Intrexon Corporation (NYSE:XON)Newburgh GazetteAnalysts take a look at Intrexon Corp (NYSE:XON) having this to say.WeeklyHubAnalyst Ratings

Here's How Intrexon Might Prove Me Wrong -- The Motley Fool - Motley Fool

Posted By BioSocrates on synthetic biology

http://news.google.com - Here's How Intrexon Might Prove Me Wrong -- The Motley FoolMotley FoolCan it really convert cheap natural gas to valuable chemicals at double digit gross margin?and more »

Intrexon to Announce Second Quarter and First Half 2017 Financial Results on August 9th - Markets Insider

Posted By BioSocrates 130 days ago on synthetic biology

http://news.google.com - Intrexon to Announce Second Quarter and First Half 2017 Financial Results on August 9thMarkets Insider... delivering unprecedented control, quality, function, and performance of living cells. We call our synthetic biology approach Better DNA®, and we invite you to discover more at www.dna.com or follow us on Twitter at @Intrexon, on Facebook, and LinkedIn.and more »

Global Synthetic Biology Market 2017- GenScript USA, New England Biolabs, Intrexon and DuPont - Digital Journal

Posted By BioSocrates on synthetic biology

http://news.google.com - Global Synthetic Biology Market 2017- GenScript USA, New England Biolabs, Intrexon and DuPontDigital JournalPune, India -- (SBWIRE) -- 07/18/2017 -- The valuation of Global Synthetic Biology Market is USD 2.64 billion in 2016. The Synthetic Biology market is estimated to reach USD 37.21 billion in 2022, growing at a CAGR of 27.70% between 2016 and 2022 ...

Intrexon Drops After CEO's Claims on Co.'s Synthetic Biology Said to be Untrustworthy: TheStreet (NYSE:XON) - Sonoran Weekly Review

Posted By BioSocrates on synthetic biology

http://news.google.com - Intrexon Drops After CEO's Claims on Co.'s Synthetic Biology Said to be Untrustworthy: TheStreet (NYSE:XON)Sonoran Weekly ReviewIntrexon (NYSE:XON) shares dropped 4% after a report in TheStreet.com from journalist Adam Feuerstein said he does not trust Intrexon chief executive officer R.J. Kirk because very few of his claims about any of the company's synthetic biology business ...

AmpliPhi punts a synthetic biology partnership with Intrexon - FierceBiotech

Posted By BioSocrates on synthetic biology

http://news.google.com - FierceBiotechAmpliPhi punts a synthetic biology partnership with IntrexonFierceBiotechOn second thought, AmpliPhi Biosciences isn't sold on Intrexon's synthetic biology tech for its anti-infectives after all. Just three days ahead of the third anniversary for their tie-up, the San Diego-based biotech is calling it quits and terminating ...AmpliPhi Biosciences (APHB) Ends Collaboration Agreement with Intrexon (XON)StreetInsider.comAmpliPhi Bio axes exclusive channel deal with IntrexonSeeking Alphaall 21 news articles »

Intrexon plays long game, corners market on synthetic biology companies - Genetic Literacy Project

Posted By BioSocrates on synthetic biology

http://news.google.com - Intrexon plays long game, corners market on synthetic biology companiesGenetic Literacy ProjectIntrexon CEO Randal J. Kirk's interest in synthetic biology is clearly an economically driven one. Kirk's reputation as a businessman is what makes acquisitions like AquaBounty with its GM salmon so interesting. Sixty-five percent of Americans have ...

Merck KGaA: Merck Serono and Intrexon Announce Agreement for the ... - The Wall Street Transcript

Posted By BioSocrates on synthetic biology

http://news.google.com - Washington Business JournalMerck KGaA: Merck Serono and Intrexon Announce Agreement for the ...The Wall Street TranscriptIntrexon Corporation (NYSE: XON) is a leader in synthetic biology focused on collaborating with companies in Health, Food, Energy, Environment, and Consumer sectors to create biologically-based products that improve the quality of life and the health ...Intrexon Corp Receives Positive Rating from Griffin Securities (XON)sleekmoneyall 27 news articles »